Trigyn Technologies has announced the resignation of Dr. Satyam Cherukuri as Chairman and Non-Executive Director, effective April 7, 2026. The announcement was made on March 10, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Leadership Transition Details

Dr. Satyam Cherukuri (DIN No.: 01294234) has tendered his resignation from his position as Chairman and Non-Executive Director on the Board of Trigyn Technologies Limited. The resignation takes effect from Monday, April 7, 2026, due to personal circumstances requiring his full attention and commitment.

Subsidiary Board Changes

Concurrently with his resignation from the parent company, Dr. Satyam Cherukuri has also stepped down as a Member of the Board of Trigyn Technologies Inc., a subsidiary of the company, with effect from April 7, 2026. This ensures a complete transition from his leadership roles across the corporate structure.

Formal Resignation Communication

In his resignation letter dated March 7, 2026, addressed to the Board members, Dr. Cherukuri stated that personal circumstances now require his full attention and commitment, making him unable to serve Trigyn with the dedication and focus that the role demands. He expressed his commitment to ensuring a smooth and orderly transition of leadership, offering to make himself fully available during the transition period to brief his successor and complete outstanding matters.

Regulatory Compliance Framework

The disclosure was made pursuant to multiple regulatory requirements including Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided comprehensive details as required under Regulation 30(6) read with Para A (7) of Part A of Schedule III of the regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Recognition

Trigyn Technologies Limited has placed on record its sincere appreciation for the valuable contributions made by Dr. Satyam Cherukuri during his tenure as Chairman and Non-Executive Director. The company acknowledged his dedication and service in the formal announcement signed by Company Secretary & Compliance Officer Anmol Chaturvedi. Dr. Cherukuri expressed gratitude for the privilege of serving alongside the Board members, carrying with him respect and admiration for their dedication.

Trigyn Technologies Limited has fulfilled its regulatory obligation by publishing its unaudited financial results for the quarter ended December 31, 2025, in newspapers as required under Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company published the results in Business Standard and Mumbai Mitra on February 12, 2026, following board approval on February 10, 2026.

Regulatory Compliance and Publication

The company submitted the newspaper publication copies to both BSE Limited (Scrip Code: 517562) and National Stock Exchange of India Limited (Company Code: TRIGYN) on February 12, 2026. Company Secretary & Compliance Officer Anmol Chaturvedi digitally signed the submission documents, ensuring compliance with stock exchange requirements.

Consolidated Financial Performance

Quarterly Results (Q3FY26)

The published results show consolidated revenue of Rs. 25,803.19 Lakhs for Q3FY26 compared to Rs. 20,669.68 Lakhs in Q3FY25. Net profit after tax reached Rs. 69.12 Lakhs for the quarter, with total comprehensive income of Rs. 964.39 Lakhs including other comprehensive income.

Nine-Month Performance (9M FY26)

For the nine months ended December 31, 2025, consolidated revenue increased to Rs. 72,448.30 Lakhs from Rs. 65,731.72 Lakhs in the corresponding period of the previous year. Net profit after tax was Rs. 135.45 Lakhs compared to Rs. 921.16 Lakhs in 9M FY25.

Standalone Financial Results

Quarterly Standalone Performance

Standalone revenue for Q3FY26 reached Rs. 6,279.23 Lakhs, significantly higher than Rs. 3,514.18 Lakhs in Q3FY25. The company reported standalone profit after tax of Rs. 132.93 Lakhs compared to Rs. 825.93 Lakhs in the previous year quarter.

Nine-Month Standalone Results

Standalone revenue for nine months increased to Rs. 14,162.45 Lakhs from Rs. 10,605.00 Lakhs in 9M FY25. However, the company reported a loss of Rs. (518.09) Lakhs compared to a profit of Rs. 68.27 Lakhs in the previous year.

Key Business Developments

The published results highlight several major contracts including the Andhra Pradesh State Fibernet Limited project worth Rs. 160 Crores and the new BharatNet Project Phase III with an expected order value of Rs. 119.74 Crores. The company continues to manage various legal proceedings while maintaining its focus on technology services across multiple geographies.